Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

Resverlogix Corp > 7 other molecules sitting in limbo!
View:
Post by narmac on Aug 10, 2020 9:51am

7 other molecules sitting in limbo!

,,I am trying to figure out for what reason these molecules sit in limbo???....is it greed by the team thinking each molecule is a blockbuster.....or is it just poor business sense to not sell one or more into the hands of an entity who has the means and the will to get them into trial,,or is it that our team just cant seem to sell the idea of epigenetics to an interested party?..price it even at a resonable dollar figure!!!,,,,,maybe give one away just to prove the science,,,if that had been done these past years and it was successful we would on the NASDAQ now,,,,anything to get us moving and humankind in a better health position,,,,,..there are probably many more possiblities,,,but if they could be sold it would add up front cash to our bottom line and possibly limit any amount of dilution,,,,maybe even get us thru BoM2,,,or 3,,or 4!,,,
Comment by general360 on Aug 10, 2020 12:03pm
uh, where did u get 7 other compounds from?  Why don't we try TWENTY! 20.  the BIG TWO-OH. where did i get my number from? i got it from MYSELF! haha, actually, DIRECTLY FROM DM HIS BAD AZZ SELF!!! the transcript from 2018 AGM Q&A: Here's the relevant excerpt, and we've talked about this yeah, before: New compounds:  actually, it was discussed very briefly at the ...more  
Comment by narmac on Aug 10, 2020 5:27pm
,,well,,,so there are twenty,,,,,twenty reasons to sell some of these molecules to interested parties,and apply that cash to BoM2,,etc,,,,,,,,DMcC's negotiating and partnering talks..hummmm..its getting so long in the tooth investors are seeing the crying wolf analogy...........and as you say g360,,,,,we could have negotiated the terms of these last number of big financings ,,,its an ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities